Christine Juday Brings Deep Life Sciences Leadership Experience to Discern

February 2021

Christine Juday, MPH recently joined Discern Health as a Vice President. In this role, Chris applies her deep experience in life sciences to connect with clients on a range of issues centered on health care quality and value. Having worked in a variety of life sciences roles, Chris can translate quality and value concepts into…

Read more

Nina Regenold Brings Multicultural Care Experience to Discern

February 2021

Nina Regenold, MSc recently joined Discern Health as a Project Analyst. In this role, Nina supports projects related to value-based care, policy, provider consolidation, and vaccination. Nina brings a strong qualitative research background and knowledge of innovative, international, and multicultural care approaches to help clients improve care and navigate the health system. Prior to joining…

Read more

Quality Outlook: Recognizing and Testing Telehealth Models in Oncology Care First

February 2021

Acceleration of the availability and use of telehealth, spurred by the COVID-19 pandemic, has created the opportunity and need for alternative payment models (APMs) that encourage implementation and enable evaluation of telehealth services. In the latest installment of Discern Health’s Quality Outlook blog series in the Journal of Clinical Pathways, Partner Tom Valuck, Director David Blaisdell, and Vice President…

Read more

Five Drug-Pricing Predictions for 2021

January 2021

W2O’s Value + Access team shared 2021 predictions for drug pricing, value, and access. Check out the team’s estimates below, and see how they tracked against last year’s predictions here. 1. Transparency Will Make a Comeback We went all-in on “transparency” two years ago, reasoning that a combination of state legislation and DTC-ad policies would…

Read more

Quality Outlook: Using Social Media to Measure Cancer Patient Experience and Outcomes

January 2021

In the last few years, social media has come to dominate much of public discourse, including for health care. In the latest installment of Discern Health’s Quality Outlook blog series in the Journal of Clinical Pathways, Partner Tom Valuck, Vice President Theresa Schmidt, Director David Blaisdell, and Manasi Tirodkar explore ways social media and the process of “social listening” can offer a…

Read more

How Life Sciences Companies Can Assess Quality and Value Strategy Progress

January 2021

Value-based care is creating new market demands for life sciences companies. Discern Health has worked with numerous life sciences clients to navigate these new demands and identify opportunities for further integration of quality and value into life sciences strategy. We have also identified concrete steps that life sciences companies can take to overcome barriers to…

Read more

Biden’s Advisors: A Drug-Pricing Reading List

December 2020

A new administration means a fresh set of policy approaches but it also means new people who can guide the process of turning those approaches into legislative and regulatory action. President-elect Biden is building out that team, which now includes California Attorney General Xavier Becerra, nominated to be Secretary of Health and Human Services, and Center for American…

Read more

Discern Develops a Framework for Life Sciences Quality and Value Strategy

December 2020

Value-based care is creating dynamic change in the US health care system. For the past 20 years, Medicare, Medicaid, and health insurers have moved steadily toward performance-based payment models for providers and health plans. These trends have motivated doctors, hospitals, and other health care providers to organize into integrated delivery systems, both to improve their…

Read more

Discern and Partners Publish Patient-Reported Measures Call to Action for Payers

December 2020

Payers play a critical role in promoting high-value patient care, and patient-reported measures (PRMs) and performance measures (PR-PMs) are key to bringing patient voices into value-based care and payment. Discern Health and the National Pharmaceutical Council (NPC) published a call to action for payers in a viewpoint article in the Journal of Managed Care Pharmacy….

Read more

Discern Leads Study to Support Arizona Serious Illness Outcomes Improvement

December 2020

Discern Health recently completed a best practices study in collaboration with the Arizona Coalition to Transform Serious Illness Care (AZ Coalition) to identify community-based strategies to help people with serious illness in Arizona manage health conditions, reduce the risk of adverse events, and increase the number of days at home. The AZ Coalition is a…

Read more